Vitamin C for Improving Lung Function in Children

Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function (VCSIP) Longer Term Follow Up

Recruiting Observational Study
Asthma Pulmonary Function Wheezing In Utero Nicotine
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
6 – 16
Sex
Any
Study type
Observational
Participants needed
225 (estimated)
Sponsor
Oregon Health and Science University · Other
Who this trial is looking for

This trial is looking for pregnant women who smoke and their children. Participants will either receive vitamin C or a placebo during pregnancy, and their children's lung function will be followed up until they are 10 years old.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am a pregnant woman who smokes.
  • I have a child who is part of the original VCSIP study.
  • I am a pregnant nonsmoker with a child enrolled in the original VCSIP study.

You may not be able to join if

  • I have withdrawn my consent to participate.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The overall aims of this protocol are to determine whether prenatal supplementation with vitamin C to pregnant smokers can improve pulmonary function at 10 years of age in their offspring. This is an additional continuation of the Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function (VCSIP) trial, to follow the offspring through 10 years of age. The hypothesis for this pro…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Women and their offspring randomized to vitamin C versus placebo during pregnancy as well as pregnant nonsmokers and their offspring enrolled as the reference group in the original VCSIP study Exclusion Criteria: * participants who specifically withdraw consent
Contacts

Cindy McEvoy, MD, MCR

503-494-0223

mcevoyc@ohsu.edu

CONTACT

Kristin Milner, BS, CMA, CCRP

503-494-0223

milner@ohsu.edu

CONTACT